Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care Conference
February 14 2017 - 8:00AM
Horizon Pharma plc (Nasdaq:HZNP), a biopharmaceutical company
focused on improving patients' lives by identifying, developing,
acquiring and commercializing differentiated and accessible
medicines that address unmet medical needs, announced today that
the company will present at the Cowen and Company 37th Annual
Health Care Conference at 2:40 p.m. ET on March 6, 2017 in Boston,
MA.
The conference presentation will be webcast live and may be
accessed by visiting Horizon's investor relations section of the
website at http://ir.horizon-pharma.com. A replay of the
webcast will be available for the event.
About Horizon Pharma plc Horizon Pharma plc is
a biopharmaceutical company focused on improving patients' lives by
identifying, developing, acquiring and commercializing
differentiated and accessible medicines that address unmet medical
needs. The Company markets 11 medicines through its orphan,
rheumatology and primary care business units. For more
information, please visit www.horizonpharma.com. Follow
@HZNPplc on Twitter or view careers on our LinkedIn page.
Contacts:
Tina Ventura
Senior Vice President, Investor Relations
investor-relations@horizonpharma.com
U.S. Media:
Geoff Curtis
Senior Vice President, Corporate Communications
media@horizonpharma.com
Ireland Media:
Ray Gordon
Gordon MRM
ray@gordonmrm.ie
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Horizon Therapeutics Pub... (NASDAQ:HZNP)
Historical Stock Chart
From Apr 2023 to Apr 2024